Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 905 (LINC00905) is a human long intergenic non-coding RNA gene. lincRNAs are RNA transcripts longer than 200 nucleotides that do not code for proteins and do not overlap protein-coding genes. They are a subtype of long non-coding RNAs (lncRNAs) with emerging regulatory roles in cell biology, including chromatin remodeling, transcriptional regulation, RNA stability, and modulation of gene expression, both in cis (regulating nearby genes) and trans (regulating distant genes). While many lincRNAs are not yet well characterized, some—including LINC00905—have been implicated in disease models, especially cancer biology where they may serve as prognostic markers or contribute to disease mechanisms. However, LINC00905 is not established as a therapeutic target, and its direct functional characterization remains limited in current databases and literature.
Not applicable; no drugs have a defined mechanism of action via this lincRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 905 (LINC00905).